Galectin Therapeutic (GALT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2017 | 03-2017 | 12-2016 | 09-2016 | 06-2016 | |
| Operating Expenses | 4,514 | 4,946 | 4,599 | 4,537 | 5,531 |
| Operating Income | -4,514 | -4,946 | -4,599 | -4,537 | -5,531 |
| Other Income | 6 | 9 | 8 | 11 | 12 |
| Pre-tax Income | -4,508 | -4,937 | -4,591 | -4,526 | -5,519 |
| Net Income Continuous | -4,508 | -4,937 | -4,591 | -4,526 | -5,519 |
| Net Income | $-4,508 | $-4,937 | $-4,591 | $-4,526 | $-5,519 |
| EPS Basic Total Ops | -0.14 | -0.15 | -0.16 | -0.16 | -0.20 |
| EPS Basic Continuous Ops | -0.13 | -0.15 | -0.15 | -0.15 | -0.19 |
| EPS Diluted Total Ops | -0.14 | -0.15 | -0.16 | -0.16 | -0.20 |
| EPS Diluted Continuous Ops | -0.13 | -0.15 | -0.15 | -0.15 | -0.19 |
| EBITDA(a) | $-4,514 | $-4,945 | $-4,597 | $-4,535 | $-5,529 |